UC Berkeley scientists identify protein that causes dengue shock as a potential vaccine target

Researchers at the University of California, Berkeley, have identified a viral protein that causes fluid loss and shock that indicate severe and potentially fatal dengue infections. Dubbed nonstructural protein 1 (NS1), it is secreted by cells infected with the mosquito-borne virus. It causes the endothelium of blood and lymph vessels to become permeable, which can lead to blood vessels that leak fluid. The researchers say that NS1 could be a prime target for drugs and should be considered in vaccine development. More

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.